Clinical trial
Thalidomide in Treating Patients With Thyroid Cancer
NCT00026533 · Kenneth Ain, Other · Completed
Key facts
| NCT number | NCT00026533 |
|---|---|
| Title | Thalidomide in Treating Patients With Thyroid Cancer |
| Official title | Phase II Trial of Thalidomide for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas and Medullary Thyroid Carcinomas |
| Lead sponsor | Kenneth Ain, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | thalidomide |
| Start date | Jun 1, 2001 |
| Primary completion | Nov 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: